Concepedia

H. Mark Kenney

HM

Statistics

Publications

21

Citations

1.1K

H-Index

17

Active since

1996

Affiliations

University of Rochester Medical Center(Current)

University of Rochester

Arthritis Northwest

Horizon Therapeutics (United States)

Center for Translational Molecular Medicine

H. Mark Kenney is an author at University of Rochester Medical Center specializing in medicine, rheumatoid arthritis, and rheumatology.

ORCID

Publications per year

1996–2023

21

Publications

21

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

, , +12

Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain

Benjamin A. Plog, Humberto Mestre, Genaro E. Olveda et al. · JCI Insight · 2018 · 105 citations · Full text

, , +17

When the air hits your brain: decreased arterial pulsatility after craniectomy leading to impaired glymphatic flow

Benjamin A. Plog, Nanhong Lou, Clifford Pierre et al. · Journal of neurosurgery · 2019 · 82 citations · Full text

, , +16

Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)

John K. Botson, John Tesser, Ralph Bennett et al. · The Journal of Rheumatology · 2020 · 65 citations · Full text

, , +9

The Highly Inducible Member of the 70 kDa Family of Heat Shock Proteins Increases Canine Distemper Virus Polymerase Activity

Michael Oglesbee, Zhenguo Liu, H. Mark Kenney et al. · Journal of General Virology · 1996 · 57 citations

, , +16

1–5 of 21